Cellectar Biosciences to Present at the Ladenburg Thalmann 2017 Healthcare Conference
MADISON, Wis., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused biotechnology company (the “company”), today announced that president and CEO Jim Caruso will present and meet with investors at the Ladenburg …